Short Interest in Axcella Health Inc. (NASDAQ:AXLA) Declines By 44.2%
Short Interest in Axcella Health Inc. (NASDAQ:AXLA) Declines By 44.2%
Axcella Health Inc. (NASDAQ:AXLA – Get Rating) was the target of a significant drop in short interest in the month of January. As of January 15th, there was short interest totalling 190,000 shares, a drop of 44.2% from the December 31st total of 340,600 shares. Based on an average daily trading volume, of 1,090,000 shares, the short-interest ratio is presently 0.2 days. Approximately 0.7% of the company's stock are sold short.
阿克塞拉健康公司 (NASDAQ: AXLA — 獲取評級) 是短期利益在一月份顯著下降的目標.截至 1 月 15 日，短期利息合共 19 萬股，較十二月三十一日共 340,600 股股份下降 44.2%。根據每日平均交易量為 1,090,000 股，短息比率目前為 0.2 天。約 0.7% 的公司股票賣空。
Analyst Ratings Changes
分析師等級變更
Several research firms recently weighed in on AXLA. SVB Leerink reissued a "market perform" rating and set a $2.00 price target (down from $6.00) on shares of Axcella Health in a research report on Friday, December 16th. HC Wainwright downgraded Axcella Health from a "buy" rating to a "neutral" rating in a report on Thursday, December 15th. Wedbush restated an "outperform" rating and set a $6.00 price target on shares of Axcella Health in a report on Wednesday, November 2nd. Finally, Chardan Capital dropped their price objective on shares of Axcella Health from $7.00 to $5.00 and set a "buy" rating on the stock in a research note on Wednesday, November 2nd.
幾家研究公司最近在 AXLA 上稱重。在 12 月 16 日（星期五）的一份研究報告中，SVB Leerink 重新發布了「市場表現」評級，並設定了 Axcella Health 股票的價格目標（從 6.00 美元下跌）。韋賴特在 12 月 15 日（星期四）的一份報告中，HC 溫賴特將阿克塞拉健康從「買入」評級降至「中性」評級。在 11 月 2 日（週三）的一份報告中，韋布什重申了「跑贏大市」評級，並設定了 6.00 美元的目標價格對阿克塞拉健康的股票。最後，查丹資本將其對 Axcella Health 股票的價格目標從 7.00 美元下降至 5.00 美元，並在 11 月 2 日（週三）的研究報告中設定了該股票的「買入」評級。
Axcella Health Stock Down 10.0 %
阿克塞拉健康股票下降 10.0%
Shares of Axcella Health stock traded down $0.08 during trading on Friday, hitting $0.69. 980,012 shares of the stock traded hands, compared to its average volume of 1,709,592. The company has a fifty day moving average price of $0.57 and a two-hundred day moving average price of $1.39. Axcella Health has a twelve month low of $0.16 and a twelve month high of $2.89. The company has a quick ratio of 1.23, a current ratio of 1.23 and a debt-to-equity ratio of 2.33.
阿克塞拉健康股票在周五交易期間下跌 0.08 美元，觸及 980,012 股股票交易手，相比其平均交易量為 1,709,592 美元。該公司的五十天移動平均價為 0.57 美元，兩百天移動平均價格為 1.39 美元。阿克塞拉健康有十二個月低點 0.16 美元，十二個月高點為 2.89 美元。該公司的快速比率為 1.23，流動比率為 1.23，債務與權益比率為 2.33。
Institutional Trading of Axcella Health
阿克塞拉健康的機構交易
Several large investors have recently made changes to their positions in AXLA. FMR LLC boosted its stake in shares of Axcella Health by 1.1% during the 2nd quarter. FMR LLC now owns 7,886,376 shares of the company's stock worth $16,009,000 after acquiring an additional 85,541 shares in the last quarter. Renaissance Technologies LLC boosted its stake in shares of Axcella Health by 13.9% during the 2nd quarter. Renaissance Technologies LLC now owns 55,700 shares of the company's stock worth $113,000 after acquiring an additional 6,800 shares in the last quarter. Dimensional Fund Advisors LP lifted its position in shares of Axcella Health by 24.2% during the 3rd quarter. Dimensional Fund Advisors LP now owns 113,085 shares of the company's stock worth $194,000 after purchasing an additional 22,007 shares during the last quarter. Commonwealth Equity Services LLC acquired a new position in shares of Axcella Health during the 3rd quarter worth about $34,000. Finally, Thrivent Financial for Lutherans acquired a new position in shares of Axcella Health during the 3rd quarter worth about $67,000. Institutional investors own 71.05% of the company's stock.
一些大型投資者最近對 AXLA 的倉位進行了更改。FMR 有限責任公司在第二季度將其在阿克塞拉健康股份的股份增加了 1.1％。在上一季度額外收購 85,541 股股票後，FMR 有限責任公司現在擁有該公司股票的 7,886,376 股股票，價值 16,009,000 美元。文藝復興技術有限責任公司在第二季度提高了其在阿克塞拉健康股份的股份 13.9%.文藝復興技術有限責任公司現在擁有該公司股票的 55,700 股價值 113,000 美元，在上個季度額外收購 6,800 股。維基金顧問 LP 在第三季度將其在阿克塞拉健康股份的地位提升了 24.2％。維基金顧問在上一季度額外購買 22,007 股股票後，現在擁有該公司股票的 113,085 股價值 194,000 美元。英聯邦股權服務有限責任公司在第三季度收購了 Axcella 健康股份的新位置，價值約為 34,000 美元。最後, 節儉金融為路德會員收購了阿克塞拉健康的股份的新位置在第三季度價值約 $67,000.機構投資者擁有公司股票的 71.05％。
Axcella Health Company Profile
阿克塞拉健康公司簡介
(Get Rating)
(取得評分)
Axcella Health, Inc is a biotechnology company. It engages in the research and development of treatment for diseases and improves health using endogenous metabolic modulator, or EMM, and compositions. Its product pipeline includes AXA1665, for the reduction in risk of recurrent overt hepatic encephalopathy, and AXA1125, for non-alcoholic steatohepatitis.
阿克塞拉健康公司是一家生物技術公司。它從事治療疾病的研究和開發，並改善健康使用內源性代謝調節器, 或 EMM, 和組合物.其產品線包括 AXA1665，用於降低復發性肝性腦病的風險，以及用於非酒精性脂肪性肝炎的 AXA1125。
Featured Stories
特色故事
- Get a free copy of the StockNews.com research report on Axcella Health (AXLA)
- MarketBeat Week in Review – 1/23- 1/27
- Why Lucid Spiked Nearly 100% In One Day
- Ride These Railroad Stocks for Growth and Income
- ASML Sees Demand For Chips Rallying This Year, Boosts Sales View
- KLA Corporation: Strength In A Troubled Semi-Market
- 獲取有關阿克塞拉健康（AXLA）的研究報告的免費副本
- 市場節拍週的回顧 — 1/23-1/27
- 為什麼清醒在一天內飆升近 100％
- 乘坐這些鐵路股票以獲得增長和收入
- ASML 今年看到籌碼需求上升，提高了銷售觀點
- KLA 公司：陷入困境的半市場中的實力
Receive News & Ratings for Axcella Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Axcella Health and related companies with MarketBeat.com's FREE daily email newsletter.
接收阿克塞拉健康日報的新聞和評分 -在下面輸入您的電子郵件地址，以通過 MarketBeat.com 的免費每日電子郵件通訊接收 Axcella Health 及相關公司的最新新聞和分析師評級的簡要每日摘要。
譯文內容由第三人軟體翻譯。